Sun Pharmaceutical Industries, India’s largest drugmaker by revenue, has received regulatory approval to manufacture and sell a generic version of Novo Nordisk’s blockbuster weight-loss drug Wegovy in India, the company said on Friday. The generic drug, semaglutide, will be launched under the brand name Noveltreat after the expiry of Novo Nordisk’s patent in March 2026. Continue Reading




